Division of Gastroenterology and Hepatology, Department of Medicine, Mayo Clinic, Rochester, MN, 55905, USA.
Division of Biomedical Statistics and Informatics, Department of Health Sciences Research, Mayo Clinic, Rochester, MN, 55905, USA.
Neurogastroenterol Motil. 2017 Oct;29(10):1-10. doi: 10.1111/nmo.13172. Epub 2017 Jul 28.
While limited data suggest that the fecal microbiota in healthy people is stable over time, the intraindividual variability of the fecal microbiota in constipated patients is unknown.
This study evaluated the intraindividual reproducibility of fecal microbiota analyzed with 16S rRNA gene sequencing in two stool samples collected without and after a laxative, respectively, in 25 healthy people and 25 constipated women. Participants completed a food record for 3 d before the stool collection. Colonic transit was measured with scintigraphy.
The constipated patients were older (48±15 vs 39±10 y, P=.02) than healthy participants but had a similar BMI. The total daily caloric intake was less (P=.005) in constipated (1265±350 kcal) than healthy participants (1597±402 kcal). Fourteen patients but only two controls (P<.005), had delayed colonic transit. For most measures of alpha (eg, Observed OTU number, Shannon index) and beta diversity (eg, Bray-Curtis dissimilarity, UniFrac, phyla level abundance), the ICCs between two stool samples were high, indicating moderate or strong agreement, and similar in healthy people and constipated patients. The ICC for the weighted UniFrac distance, which is weighted by abundance, was lower than its unweighted counterpart, indicating that the unweighted measure is more robust and reproducible.
The intraindividual reproducibility of fecal microbiota in constipated patients is high and comparable to healthy participants. For most purposes, evaluating the fecal microbiota in a single stool sample should generally suffice in adequately powered studies of healthy and constipated patients.
虽然有限的数据表明健康人群的粪便微生物群在一段时间内是稳定的,但便秘患者粪便微生物群的个体内变异性尚不清楚。
本研究评估了 25 名健康人和 25 名便秘女性分别在未使用和使用泻药后采集的两份粪便样本中 16S rRNA 基因测序分析的粪便微生物群的个体内重现性。参与者在粪便采集前完成了 3 天的食物记录。使用闪烁扫描法测量结肠传输。
便秘患者年龄较大(48±15 岁比 39±10 岁,P=.02),但 BMI 相似。便秘患者的总日热量摄入较少(P=.005)(1265±350 千卡)比健康参与者(1597±402 千卡)。14 名患者但只有 2 名对照者(P<.005)存在结肠传输延迟。对于 alpha 多样性的大多数指标(例如,Observed OTU 数,Shannon 指数)和 beta 多样性(例如,Bray-Curtis 不相似性,UniFrac,门水平丰度),两个粪便样本之间的 ICC 较高,表明存在中度或强一致性,在健康人和便秘患者中相似。加权 UniFrac 距离的 ICC 低于其未加权对应物,表明未加权测量更稳健且重现性更好。
便秘患者粪便微生物群的个体内重现性较高,与健康参与者相当。对于大多数目的,在健康和便秘患者的充分有力研究中,评估单个粪便样本中的粪便微生物群通常就足够了。